Clinical characteristics of eight patients with congenital nephrogenic diabetes insipidus. Endocrine. 2004;24:55–9.PubMedCrossRef 15. Ashida A, Yamamoto D, Nakakura H, Matsumura H, Uchida S, Sasaki S, et al. A case of nephrogenic diabetes insipidus with a novel missense mutation in the AVPR2 gene. Pediatr Nephrol. 2007;22:670–3.PubMedCrossRef 16. Fujimoto M, Imai K, Hirata K, Kashiwagi R, Morinishi Y, Kitazawa K, et al. Immunological profile IWR-1 concentration in a

family with nephrogenic diabetes insipidus with a novel 11 kb deletion in AVPR2 and ARHGAP4 genes. BMC Med Genet. 2008;9:42.PubMedCrossRef 17. Bichet DG, Birnbaumer M, Lonergan M, Arthus MF, Rosenthal W, Stattic Goodyer P, et al. Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus. Am J Hum Genet. 1994;55:278–86.PubMed

18. Bichet DG, Arthus MF, Lonergan M, Hendy GN, Paradis AJ, Fujiwara TM, et al. X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis. J Clin Invest. 1993;92:1262–8.PubMedCrossRef 19. Spanakis E, Milord E, Gragnoli C. AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance. J Cell Physiol. TPCA-1 molecular weight 2008;217:605–17.PubMedCrossRef 20. Sasaki S. Aquaporin 2: from its discovery to molecular structure and medical implications. Mol Asp Med. 2012;33:535–46.CrossRef 21. Faerch M, Christensen JH, Corydon TJ, Kamperis K, de Zegher F, Gregersen N, et al. Partial nephrogenic diabetes insipidus caused by a novel mutation in the AVPR2

gene. Clin Endocrinol (Oxf). 2008;68:395–403.CrossRef 22. Moses AM, Sangani G, Miller JL. Proposed cause of marked vasopressin resistance in a female with an X-linked recessive V2 receptor abnormality. J Clin Endocrinol Metab. 1995;80:1184–6.PubMedCrossRef 23. van Lieburg AF, Verdijk MA, Schoute F, Ligtenberg MJ, van Oost BA, Waldhauser F, et al. Clinical phenotype of nephrogenic diabetes insipidus in females heterozygous for a vasopressin type 2 receptor mutation. Hum Genet. 1995;96:70–8.PubMedCrossRef PRKACG 24. Nomura Y, Onigata K, Nagashima T, Yutani S, Mochizuki H, Nagashima K, et al. Detection of skewed X-inactivation in two female carriers of vasopressin type 2 receptor gene mutation. J Clin Endocrinol Metab. 1997;82:3434–7.PubMedCrossRef 25. Satoh M, Ogikubo S, Yoshizawa-Ogasawara A. Correlation between clinical phenotypes and X-inactivation patterns in six female carriers with heterozygote vasopressin type 2 receptor gene mutations. Endocr J. 2008;55:277–84.PubMedCrossRef 26. Sahakitrungruang T, Wacharasindhu S, Sinthuwiwat T, Supornsilchai V, Suphapeetiporn K, Shotelersuk V. Identification of two novel aquaporin-2 mutations in a Thai girl with congenital nephrogenic diabetes insipidus. Endocrine. 2008;33:210–4.PubMedCrossRef 27. Tajima T, Okuhara K, Satoh K, Nakae J, Fujieda K. Two novel aquaporin-2 mutations in a sporadic Japanese patient with autosomal recessive nephrogenic diabetes insipidus. Endocr J. 2003;50:473–6.PubMedCrossRef 28.